Did you know ? Visit bioMérieux during Medlab Middle East 2024 from 5-8 February, and enter a world of simplicity with our recently launched VIDAS® KUBE™, the advanced generation of the VIDAS® immunoassay solution which has been trusted by labs around the world for more than 30 years. Speak with our teams at booth Z5.D10 to find out more about how this solution, combined with advanced technology, is designed to preserve everything that labs appreciate about the VIDAS® Solution. Read more here 👉https://lnkd.in/ew4Gwr2m @Medlab #MedlabMiddleEast #Pioneering Diagnostics #BeAGameChanger #Immunoassay
bioMérieux Clinical Diagnostics (IVD)
Biotechnology
You can make a difference with the right test that give you the power to fight infectious diseases, and save lives.
About us
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP
- Website
-
http://www.biomerieux-diagnostics.com
External link for bioMérieux Clinical Diagnostics (IVD)
- Industry
- Biotechnology
- Company size
- 10,001+ employees
- Headquarters
- Marcy l'Etoile
- Founded
- 1963
- Specialties
- In Vitro Diagnostics, IVD, Microbiology, Infectious Diseases, Antimicrobial Resistance, AMR, Antimicrobial Stewardship, Sepsis, Respiratory Infections, AKI, and TBI
Updates
-
Don’t miss this update! The latest software version* is now available for our BIOFIRE FILMARRAY 2.0 and TORCH Systems! 🌐 Develop system connectivities with new smart options! #syndromictesting #update #connectivity * Product availability may vary by country. Consult your bioMérieux representative to validate the eligibility of your system for this version update https://bddy.me/3SoCcWD
-
-
📢 Calling all laboratory professionals, microbiologists, and clinicians eager to enhance their expertise in the clinical dimensions of microbiology! Explore APSCMI's online course to deepen your comprehension of microbiology's pivotal role in clinical practice! 👉 https://lnkd.in/gekGc3MR
-
-
Menia Koukougianni, patient advocate for antimicrobial resistance (AMR) and founder of NGO Karkinaki, shares her personal family story about her daughter’s journey with cancer and how diagnostics play a critical role in mitigating an antimicrobial resistant infection. Watch Menia’s full Patient Advocate Testimonial Video: https://lnkd.in/eFGnurv8
-
Don’t miss this update! The latest software version* is now available for our BIOFIRE FILMARRAY 2.0 and TORCH Systems ⬇️ Take the power and do it yourself! #syndromictesting #update * Product availability may vary by country. Consult your bioMérieux representative to validate the eligibility of your system for this version update https://bddy.me/49gAwFt
-
-
It’s #WorldNTDDay, Neglected Tropical Diseases (NTDs) include several parasitic viral, bacterial, fungal and non-communicable diseases that cause substantial illness for more than one billion people globally. 🦟 dengue and chikungunya are among the most important diseases caused by arboviruses worldwide, especially in tropical and subtropical regions. These are transmitted to humans by day-biting Aedes aegypti and Aedes albopictus mosquitoes. bioMérieux Immunoassays offer directed against diseases improve access to medically important automated serological assays to optimize patient management. Discover VIDAS® ARBOVIRUSES PANEL 👉 https://bddy.me/4bk3578 Together we can #BeatNTDs #PIONEERINGDIAGNOSTICS #VIDAS
-
Less than 10 days to Medlab Middle East 5-8 February. 📍 Find bioMérieux at booth Z5.D10 to discover what changes everything! #WeArebioMérieux #Gamerchangerfor60years
📣 📣 bioMérieux is once again proud to participate in Medlab Middle East #Dubai as a Diamond Partner and share our exciting game changing innovations! Meet the bioMérieux team in person at our booth Z5.D10 from 5-8 February or online from 22 January, to discover, and exchange insights on Antimicrobial Stewardship, #Sepsis Management, Point-of-Care solutions, and #EmergencyCare, among others. Find out more information here 👉 https://lnkd.in/ew4Gwr2m @medlab #MedlabMiddleEast #Pioneering Diagnostics #BeAGameChanger #AMS
-
-
Don’t miss this update! The latest software version* is now available for our BIOFIRE FILMARRAY 2.0 and TORCH Systems! Discover the new selective reporting feature for C. difficile for the BIOFIRE Gastrointestinal (GI) Panel. #cdifficile #gastrointestinal #GI #syndromictesting #update #flexibility * Product availability may vary by country. Consult your bioMérieux representative to validate the eligibility of your system for this version update https://bddy.me/3UeVel6
-
-
Don’t miss this update! The latest software version* is now available for our BIOFIRE FILMARRAY 2.0 and TORCH Systems! 🔎 Get new features to upgrade your daily workflow! #syndromictesting #update * Product availability may vary by country. Consult your bioMérieux representative to validate the eligibility of your system for this version update https://bddy.me/3SfKssh
-
-
True to our pioneering spirits, bioMérieux is rethinking the power of molecular infectious disease diagnostics with our latest advancement. Be one of the first game changers in the region to discover our Point-Of-Care solution that changes everything at the MedLab Middle East 2024 ! Meet the bioMérieux team in person at our booth Z5.D10 from 5-8 February or online from 22 January to find out more about this newest innovation. Discover more here 👉 https://lnkd.in/ew4Gwr2m @Medlab #MedlabMiddleEast #Pioneering Diagnostics #BeAGameChanger
-